North Smithfield, RI, United States of America

Stephanie Joy Bouley

This inventor holds 2 USPTO granted patents. Top assignee: Dartmouth College. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephanie Joy Bouley. Retrieved from https://idiyas.com/inventor/stephanie-joy-bouley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stephanie Joy Bouley: Inventor in Cancer Research and Therapeutics

Introduction

Stephanie Joy Bouley is an inventor based in North Smithfield, Rhode Island. Her patent work includes compounds and methods related to cancer research and the treatment of disorders associated with NF1 or RAS signaling. She is affiliated with Dartmouth College.

Latest Patents

Bouley is named on two patents. One, “Composition and Method for Inhibiting BORC Complex to Treat Cancers with NF1 Deficiency and Dysregulated RAS Signaling,” describes methods and compositions for identifying potential therapeutic agents and treating NF1- or RAS-associated disorders.

Her other patent, “Vinylogous Thioester Compounds and Methods of Use,” covers vinylogous thioester compounds and methods for using them.

Career Highlights

Bouley’s patent portfolio reflects research focused on therapeutic approaches and chemical compounds. Her work connects the study of cancer-related signaling with methods for identifying and developing potential treatments.

Collaborations

Bouley’s listed coworkers include Yolanda Sanchez and Matthew Wood. Her affiliation with Dartmouth College places her work within an academic research environment.

Conclusion

With 2 patents addressing therapeutic methods and compounds, Stephanie Joy Bouley’s inventions contribute to research on NF1- and RAS-associated disorders and potential cancer treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…